Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
25 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.120,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
topotecan
manufacturer/tradename
USP
mp
260 °C (dec.) (lit.)
application(s)
pharmaceutical
pharmaceutical (small molecule)
pharmaceutical
format
neat
SMILES string
CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5ccccc5nc34)C2=O
InChI
1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1
InChI key
VSJKWCGYPAHWDS-FQEVSTJZSA-N
General description
Application
Analysis Note
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description certified reference material, pharmaceutical secondary standard | description phyproof® Reference Substance | description ≥90% (HPLC), powder |
| grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade primary reference standard | grade - |
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename PhytoLab | manufacturer/tradename - |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical | application(s) - | application(s) - |
| format neat | format - | format - | format - |
| agency USP | agency traceable to USP 1672280 | agency - | agency - |
| API family topotecan | API family - | API family - | API family - |
Still not finding the right product?
Explore all of our products under Topotecan-verwandte Verbindung C
Signalwort
Danger
Gefahrencodes
Sicherheitshinweise
Hazard Classifications
Acute Tox. 3 Oral - Muta. 1B
Lagerklasse
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
Was ist los?
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.


